For research use only. Not for therapeutic Use.
Vutiglabridin(Cat No.:I045088)is a synthetic derivative of glabridin, developed as a mitochondrial function enhancer and metabolic regulator. It is being investigated for its potential to treat metabolic disorders, including obesity, type 2 diabetes, and age-related metabolic decline. Vutiglabridin activates AMPK and improves mitochondrial respiration, promoting energy expenditure and reducing inflammation and oxidative stress. Unlike its natural counterpart, it offers improved bioavailability and stability. By targeting cellular energy balance, Vutiglabridin may reverse metabolic dysfunction and delay aging-related physiological decline.
CAS Number | 1800188-47-9 |
Synonyms | 2-(8,8-dimethyl-3,4,9,10-tetrahydro-2H-pyrano[2,3-h]chromen-3-yl)-5-ethoxyphenol |
Molecular Formula | C22H26O4 |
Purity | ≥95% |
IUPAC Name | 2-(8,8-dimethyl-3,4,9,10-tetrahydro-2H-pyrano[2,3-h]chromen-3-yl)-5-ethoxyphenol |
InChI | InChI=1S/C22H26O4/c1-4-24-16-6-7-17(19(23)12-16)15-11-14-5-8-20-18(21(14)25-13-15)9-10-22(2,3)26-20/h5-8,12,15,23H,4,9-11,13H2,1-3H3 |
InChIKey | IUXJXQLTUMGHHL-UHFFFAOYSA-N |
SMILES | CCOC1=CC(=C(C=C1)C2CC3=C(C4=C(C=C3)OC(CC4)(C)C)OC2)O |
Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |